Near Infrared Spectroscopy in Patients Undergoing Robotic Assisted Laparoscopic Surgery in the Trendelenburg Position

Sponsor
Medical University of Vienna (Other)
Overall Status
Unknown status
CT.gov ID
NCT02829242
Collaborator
(none)
40
1
53
0.8

Study Details

Study Description

Brief Summary

Some robotic endoscopic surgeries require a steep Trendelenburg position and a carbon dioxide pneumoperitoneum. This minimally invasive approach has the advantages of less postoperative pain, shorter hospital stay and faster recovery. After prolonged operative time in a Trendelenburg position rare but significant complications are a cerebral oedema or a well leg compartment syndrome.

Well leg compartment syndrome results from inadequate perfusion in the lower limbs and the perfusion pressure is decreased proportionally to the lower extremity elevation. The condition can lead to release of intracellular proteins and myoglobinuria, hyperpotassaemia and metabolic acidosis followed by cell necrosis. The risk for tissue damage increases after 4 hours in a Trendelenburg position.

If not promptly diagnosed and treated, a compartment syndrome has devastating complications like permanent dysfunction, limb loss, renal failure or even death.

There are no specific guidelines for diagnosis and for the timing of surgical decompression. Fasciotomy is a clinical decision. There is no universal agreement at which compartment pressure irreversible muscle damage occurs.

The only objective diagnostic tool available is currently to measure the intramuscular pressure, however this is invasive, painful and may yield unreliable results. An intracompartment pressure of 0- 10mm Hg is the normal range.

Near Infrared Spectroscopy (NIRS) monitors are validated and approved to measure cerebral and somatic tissue oxygenation below the sensors and may help detecting promptly a compartment syndrome.

Therefore, the investigators designed the present study to detect a change in the tissue oxygenation in the lower legs during robotic assisted, laparoscopic surgery in the Trendelenburg position.

Condition or Disease Intervention/Treatment Phase
  • Device: NIRS Monitoring (SenSmart Monitor)

Study Design

Study Type:
Observational
Anticipated Enrollment :
40 participants
Observational Model:
Case-Only
Time Perspective:
Prospective
Official Title:
Near Infrared Spectroscopy for Determination of Tissue Oxygenation in Patients Undergoing Robotic Assisted Laparoscopic Surgery in the Trendelenburg Position - A Feasibility Study
Study Start Date :
Jul 1, 2016
Anticipated Primary Completion Date :
Dec 1, 2020
Anticipated Study Completion Date :
Dec 1, 2020

Arms and Interventions

Arm Intervention/Treatment
Prostatic Surgery

Patient scheduled for a robotic assisted laparoscopic prostatic surgery.

Device: NIRS Monitoring (SenSmart Monitor)

Colorectal Surgery

Patient scheduled for a robotic assisted laparoscopic colorectal surgery.

Device: NIRS Monitoring (SenSmart Monitor)

Outcome Measures

Primary Outcome Measures

  1. Tissue oxygenation in the lower limbs during surgery in the Trendelenburg position. [during the operation]

    Change over time in tissue oxygenation in the lower limbs during surgery in the Trendelenburg position.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 85 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • patients scheduled for robotic assisted laparoscopic surgery in a Trendelenburg position
Exclusion Criteria:
  • Preexisting moderate neurological disease

  • Moderate cerebrovascular disease

  • Coronary disease with angina pectoris (CCS ≥ 1)

  • Peripheral arterial disease II (with intermittent claudicatio)

  • Cardiac insufficiency (NYHA >2)

  • Tumour in pharynx, larynx or oesophagus, an aneurysm of the thoracic aorta

Contacts and Locations

Locations

Site City State Country Postal Code
1 Medical University of Vienna Vienna Austria 1090

Sponsors and Collaborators

  • Medical University of Vienna

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Barbara Kabon, MD, Medical University of Vienna
ClinicalTrials.gov Identifier:
NCT02829242
Other Study ID Numbers:
  • NIRS_RALS
First Posted:
Jul 12, 2016
Last Update Posted:
Jul 13, 2020
Last Verified:
Jul 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Keywords provided by Barbara Kabon, MD, Medical University of Vienna
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 13, 2020